ISSN 1662-4009 (online)

ey0019.11-17 | Weight regulation and endocrine circuits (including interventions) | ESPEYB19

11.17. Critical review of bariatric surgical outcomes in patients with Prader-Willi syndrome and other hyperphagic disorders

MG Gantz , DJ Driscoll , JL Miller , JB Duis , MG Butler , L Gourash , J Forster , AO Scheimann

ascheim1@jhmi.edu Obesity (Silver Spring) 2022, 30(5):973–981 https://doi.org/10.1002/oby.23385Brief Summary: This review analyzes the outcomes after bariatric procedures among patients with Prader-Willi syndrome (PWS), melanocortin 4 receptor (MC4R) mutations, Bardet-Biedl syndrome (BBS), and hypothalamic obesity (HO). The benef...

ey0019.13-3 | Improving access to healthcare in pediatric endocrinology and diabetes | ESPEYB19

13.3. The role of non-governmental organizations in strengthening healthcare systems in low- and middle-income countries: lessons from Sante Diabete in Mali

B Besancon , A Sidibe , DS Sow , O Sy , J Ambard , JS Yudkin , D Beran

David.Beran@unige.ch Glob. Health Action 2022, VOL. 15, 2061239; doi: 10.1080/16549716.2022.2061239Brief Summary: In this perspective, the authors argue that non-governmental organisations (NGO), such as Santé Diabète, can play a role in the strengthening of health systems and can improve leadership and governance, service delivery and...

ey0019.13-17 | Endocrinology | ESPEYB19

13.17. Health-related quality of life and fatigue perception in children with congenital adrenal hyperplasia: a developing nation perspective

R Daniel , J Yadav , R Kumar , P Malhi , A Sharma , D Dayal

jai1984yadav@gmail.com Pediatr Endocrinol Diabetes Metab 2021; 27: 266–271. doi: 10.5114/pedm.2021.109269Brief Summary: The questionnaire-based case control study found that children with classical congenital adrenal hyperplasia (CAH) in northern India reported lower quality of life (QOL), poorer sleep and increased fatigue compared to healthy...

ey0019.14-9 | Risk and Outcome | ESPEYB19

14.9. A proteomic surrogate for cardiovascular outcomes that is sensitive to multiple mechanisms of change in risk

SA Williams , R Ostroff , MA Hinterberg , J Coresh , CM Ballantyne , K Matsushita , CE Mueller , J Walter , C Jonasson , RR Holman , SH Shah , N Sattar , R Taylor , ME Lean , S Kato , H Shimokawa , Y Sakata , K Nochioka , CR Parikh , SG Coca , T Omland , J Chadwick , D Astling , Y Hagar , N Kureshi , K Loupy , C Paterson , J Primus , M Simpson , NP Trujillo , P Ganz

Sci Transl Med. 2022 Apr 6;14(639):eabj9625; PMID 35385337 doi: 10.1126/scitranslmed.abj9625https://www.science.org/doi/10.1126/scitranslmed.abj9625Brief Summary: This international study, led by Dr. Stephens Williams from Boulder, Colorado, USA, developed a surrogate biomarker from 27 circulating proteins to predict ...

ey0017.2-1 | Neonatal Hypoglycaemia | ESPEYB17

2.1. Clinical and genetic characterization of 153 patients with persistent or transient congenital hyperinsulinism

JME Mannisto , M Maria , J Raivo , T Kuulasmaa , T Otonkoski , H Huopio , Laakso

To read the full abstract: J Clin Endocrinol Metab. 2020 Apr 1;105(4). PMID: 32170320In congenital hyperinsulinism (CHI) there is dysregulation of insulin secretion that leads to persistent hypoglycaemia. Mutations in the ABCC8/KCNJ11 genes which encode the pancreatic KATP channels proteins (SUR1/KIR6.2 respectively) are the most common causes of CHI. Mutations ...

ey0017.2-4 | Neonatal Hypoglycaemia | ESPEYB17

2.4. Targeting glucose control in preterm infants: Pilot studies of continuous glucose monitoring

L Thomson , D Elleri , S Bond , J Howlett , DB Dunger , K Beardsall

To read the full abstract: Arch Dis Child Fetal Neonatal Ed. 2019 Jul;104(4):F353–F359. PMID:30232094.In preterm and in the very low birthweight infants, hyperglycaemia is associated with increased risks of mortality, brain injury, retinopathy of prematurity and worse neurodevelopmental outcomes (1). Treatment of hyperglycaemia with continuous insulin infusion leads to increas...

ey0017.2-17 | Maternal Obesity and Long-Term Infant Consequences | ESPEYB17

2.17. Children exposed to maternal obesity or gestational diabetes mellitus during early fetal development have hypothalamic alterations that predict future weight gain

KA Page , S Luo , X Wang , T Chow , J Alves , TA Buchanan , AH Xiang

To read the full abstract: Diabetes Care. 2019 Aug;42(8):1473–1480. PMID: 31332028Maternal obesity and gestational diabetes (GDM) increase the risk of offspring developing childhood obesity and type 2 diabetes. The underlying mechanisms and possible neuronal pathways are unknown but might involve changes in the hypothalamic structure and function. Novel non-invasive imaging te...

ey0017.2-19 | Maternal Obesity and Long-Term Infant Consequences | ESPEYB17

2.19. Prolonged prepregnant maternal high-fat feeding reduces fetal and neonatal blood glucose concentrations by enhancing fetal [beta]-cell development in C57BL/6 mice

L Qiao , JS Wattez , L Lim , PJ Rozance , WW Jr Hay , J Shao

To read the full abstract: Diabetes. 2019 Aug;68(8):1604–1613. doi: 10.2337/db18-1308. Epub 2019 May 24. PMID: 31127056Maternal obesity is an important risk factor for neonatal hypoglycaemia. Maternal BMI predicts the risk of neonatal hypoglycaemia independently from maternal obesity suggesting that the link between maternal adiposity and neonatal hypoglycaemia is complex. Identifying the u...

ey0017.2-22 | Neonatal Oxytocin and Brain Development | ESPEYB17

2.22. Expression of synaptic proteins in the hippocampus is modulated by neonatal oxytocin treatment

B Filova , A Reichova , M Zatkova , A Srancikova , S Bukatova , Z Bacova , J Bakos

To read the full abstract: Neurosci Lett. 2020 Apr 23;725:134912. doi: 10.1016/j.neulet.2020.134912. Epub 2020 Mar 12. PMID: 32173625Oxytocin is the main neuropeptide regulating sociality and is expressed in neurons exclusively localized in the hypothalamus. Abnormalities in oxytocin signaling are associated with neurodevelopmental disorders such as autism. Oxytocin plays a role in th...

ey0017.5-1 | Novel Treatments for Rare Skeletal Disorders | ESPEYB17

5.1. C-Type natriuretic peptide analogue therapy in children with achondroplasia

R Savarirayan , M Irving , CA Bacino , B Bostwick , J Charrow , V Cormier-Daire , KH Le Quan Sang , P Dickson , P Harmatz , J Phillips , N Owen , A Cherukuri , K Jayaram , GS Jeha , K Larimore , ML Chan , A Huntsman Labed , J Day , J Hoover-Fong

To read the full abstract: N Engl J Med. 2019 Jul 4;381(1):25–35.In brief: Inhibition of endochondral ossification in Achondroplasia leads to disproportionate short stature. In this phase 2 study, daily subcutaneous injection of vosoritide, a biologic analogue of C-type natriuretic peptide and a potent stimulator of endochondral ossification, results in sustained increase in t...